As the year comes to a close, we would like to recognize all of the people who have contributed to the growth and continued success of Contemporary OB/GYN.
Catherine Y. Spong, MD
Since joining Contemporary OB/GYN in April as Editor-in-Chief, Catherine Y. Spong, MD has gracefully and skillfully led our team through a year no one saw coming.
Jon I. Einarsson, MD, MPH, PHD
Thank you to our Deputy Editor, Jon I. Einarsson, MD, MPH, PHD, for his continued support and valuable contributions.
Thank you to the esteemed members of our Editorial Advisory Board; We appreciate all of the work you do. We would also like to recognize the Board’s newest members who joined with enthusiasm, despite a global pandemic: Yalda Afshar, MD, PHD, Christine Isaacs, MD, and Laura Riley, MD. Welcome to the team!
Thank you to former Editorial Advisory Board member Sharon T. Phelan, MD, for her keen insights and expertise, and to Judith M. Orvos, long-time editorial consultant, whose contributions have helped shape the magazine into what it is today.
We are excited to begin another year with such a distinguished team behind us, and with you, our readers, to join the conversation as learners, practitioners and educators. We are eager to begin another wonderful year with you.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More